| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |